About
Apollo Endosurgery is a medical device company based in Austin, Texas, founded in 2005. The company specializes in developing minimally invasive endoscopic technologies for treating gastrointestinal disorders, including obesity, chronic reflux, and cancer. It originated from a collaboration of leading gastroenterologists and surgeons aimed at advancing therapeutic endoscopy. The company’s mission is to provide less invasive surgical options that minimize trauma by utilizing natural orifices for access, thus avoiding external incisions. Their product portfolio includes the OverStitch Endoscopic Suturing System, which facilitates endoscopic tissue approximation, and the Orbera Weight Loss System, a gastric balloon designed to assist with weight loss. Apollo Endosurgery also offers the Lap-Band System and related laparoscopic accessories. Apollo's technologies are available in over 80 countries, targeting patients who have not found success with conventional treatments. In 2020, Apollo Endosurgery was acquired by Boston Scientific, enhancing its capabilities in providing innovative endoscopic solutions for gastrointestinal diseases and obesity.
Technologies
Keywords
Company Information
-
Employees 210
-
Founded 2006
-
Annual Revenue $76856000
-
Total Funding $230629000
Location
1120 South Capital of Texas Highway, Austin, Texas, United States, 78746